Sun-Organon buyout shows Indian Pharma's big hunger for overseas M&As — Here's a list of other major deals
Summary
Indian drug companies are seeking overseas growth through acquisitions to diversify beyond generics amid global challenges. Here are some other big pharma deals...
Description
Indian drug companies are seeking overseas growth through acquisitions to diversify beyond generics amid global challenges. Here are some other big pharma deals...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source